Your Online Health Information Site

Advertisement

Melanoma Survival Improved With The Immunomodulator Opdivo®

Melanoma Survival Improved With The Immunomodulator Opdivo®

A new study presented at an American Cancer Research Conference in New Orleans has shown that melanoma survival improved with the immunomodulator Opdivo®. After 5 years of treatment with Opdivo® 34% of patients were alive, while only 16% of melanoma patients receiving conventional tre
Read More